Company Filing History:
Years Active: 2006-2009
Title: Mark D McEuen: Innovator in Psoriasis Treatment
Introduction
Mark D McEuen is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of psoriasis. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
His latest patents focus on compositions and methods for diagnosing or treating psoriasis. One aspect of his invention provides isolated nucleic acid molecules that encode a CAN-1 polypeptide or an STG polypeptide. Additionally, he has developed isolated STG polypeptides, isolated CAN-1 polypeptides, and isolated SEEK-1 polypeptides. His patents also include isolated antibodies that specifically bind to CAN-1, SEEK-1, or STG polypeptides. Furthermore, he has outlined methods for diagnosing or predicting an individual's susceptibility to psoriasis, as well as methods for ameliorating the symptoms and progression of the condition.
Career Highlights
Throughout his career, Mark has worked with prominent companies such as UCB S.A. and Celltech R&D Limited. His experience in these organizations has contributed to his expertise in the field of biotechnology and pharmaceuticals.
Collaborations
Mark has collaborated with notable professionals, including Patrick R Charmley and Patrick D Moss. These partnerships have likely enhanced his research and development efforts.
Conclusion
Mark D McEuen is a distinguished inventor whose work in psoriasis treatment showcases his innovative spirit and dedication to improving healthcare. His contributions are paving the way for advancements in medical science.